Prof. Dr. med. Stephan Brand
Gastroenterologie | Hepatologie · Dept. I
Rate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-alpha antibodies
Beigel F, Deml M, Schnitzler F, Breiteneicher S, Göke B, Ochsenkühn T, Brand S. Rate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-alpha antibodies. PloS one 2014; 9:e99293.
16.06.2014Rate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-alpha antibodies
16.06.2014PloS one 2014; 9:e99293
Beigel Florian, Deml Matthias, Schnitzler Fabian, Breiteneicher Simone, Göke Burkhard, Ochsenkühn Thomas, Brand Stephan
Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies
Beigel F, Brand S, Seiderer J, Göke B, Laubender R, Van Steen K, John J, Breiteneicher S, Tillack C, Schnitzler F, Steinborn A, Ochsenkühn T. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies. Pharmacoepidemiol Drug Saf 2014; 23:735-44.
30.04.2014Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies
30.04.2014Pharmacoepidemiol Drug Saf 2014; 23:735-44
Beigel Florian, Brand Stephan, Seiderer Julia, Göke Burkhard, Laubender Rüdiger P, Van Steen Kristel, John Jestinah Mahachie, Breiteneicher Simone, Tillack Cornelia, Schnitzler Fabian, Steinborn Anni, Ochsenkühn Thomas
Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members
Beigel F, Friedrich M, Probst C, Sotlar K, Göke B, Diegelmann J, Brand S. Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members. PloS one 2014; 9:e93498.
07.04.2014Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members
07.04.2014PloS one 2014; 9:e93498
Beigel Florian, Friedrich Matthias, Probst Corina, Sotlar Karl, Göke Burkhard, Diegelmann Julia, Brand Stephan
Protective mucosal immunity mediated by epithelial CD1d and IL-10
Olszak T, Nakajima A, Mizuguchi H, Kawasaki K, Nagata K, Müller W, Snapper S, Schreiber S, Kaser A, Zeissig S, Katayama K, Wada K, Neves J, Dowds C, Baker K, Glickman J, Davidson N, Lin C, Jobin C, Brand S, Sotlar K, Blumberg R. Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature 2014; 509:497-502.
06.04.2014Protective mucosal immunity mediated by epithelial CD1d and IL-10
06.04.2014Nature 2014; 509:497-502
Olszak Torsten, Nakajima Atsushi, Mizuguchi Hiroyuki, Kawasaki Kunito, Nagata Kazuhiro, Müller Werner, Snapper Scott B, Schreiber Stefan, Kaser Arthur, Zeissig Sebastian, Katayama Kazufumi, Wada Koichiro, Neves Joana F, Dowds C Marie, Baker Kristi, Glickman Jonathan, Davidson Nicholas O, Lin Chyuan-Sheng, Jobin Christian, Brand Stephan, Sotlar Karl, Blumberg Richard S
Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2
Diegelmann J, Glas J, Franke A, Göke B, Bedynek A, Olszak T, Zimmermann E, Le Bras E, Czamara D, Brand S. Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2. PloS one 2013; 8:e77773.
05.11.2013Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2
05.11.2013PloS one 2013; 8:e77773
Diegelmann Julia, Glas Jürgen, Franke Andre, Göke Burkhard, Bedynek Andrea, Olszak Torsten, Zimmermann Eva, Le Bras Emmanuelle, Czamara Darina, Brand Stephan
Functional relevance of the cannabinoid receptor 2 - heme oxygenase pathway: a novel target for the attenuation of portal hypertension
Steib C, Gmelin L, Pfeiler S, Schewe J, Brand S, Göke B, Gerbes A. Functional relevance of the cannabinoid receptor 2 - heme oxygenase pathway: a novel target for the attenuation of portal hypertension. Life Sci 2013; 93:543-51.
03.09.2013Functional relevance of the cannabinoid receptor 2 - heme oxygenase pathway: a novel target for the attenuation of portal hypertension
03.09.2013Life Sci 2013; 93:543-51
Steib Christian J, Gmelin Leonore, Pfeiler Susanne, Schewe Julia, Brand Stephan, Göke Burkhard, Gerbes Alexander L
High-density genotyping study identifies four new susceptibility loci for atopic dermatitis
Weidinger S, Duerr R, Boehm B, Illig T, Winkelmann J, Fölster-Holst R, Nöthen M, Hoffmann P, Zhang X, Yang S, Zuo X, Büning C, Brand S, Franke A, Lee Y, Schreiber S, Irvine A, McLean W, Brown S, Kabesch M, Fahy C, McAleer M, Glas J, Sun L, Elder J, Stuart P, Maintz L, Michel S, Novak N, Schaarschmidt H, Hübner N, Marenholz I, Matanovic A, Rodríguez E, Esparza-Gordillo J, Baurecht H, Werfel T, Meyer-Hoffert U, Tsoi L, Nakamura Y, Takahashi A, Kubo M, Tamari M, Hirota T, Herder C, Heim K, Prokisch H, Hotze M, Ellinghaus D. High-density genotyping study identifies four new susceptibility loci for atopic dermatitis. Nat Genet 2013; 45:808-12.
02.06.2013High-density genotyping study identifies four new susceptibility loci for atopic dermatitis
02.06.2013Nat Genet 2013; 45:808-12
Weidinger Stephan, Duerr Richard H, Boehm Bernhard O, Illig Thomas, Winkelmann Juliane, Fölster-Holst Regina, Nöthen Markus M, Hoffmann Per, Zhang Xuejun, Yang Sen, Zuo Xianbo, Büning Carsten, Brand Stephan, Franke Andre, Lee Young-Ae, Schreiber Stefan, Irvine Alan D, McLean W H Irwin, Brown Sara, Kabesch Michael, Fahy Caoimhe M, McAleer Maeve A, Glas Jürgen, Sun Liangdan, Elder James T, Stuart Philip, Maintz Laura, Michel Sven, Novak Natalija, Schaarschmidt Heidi, Hübner Norbert, Marenholz Ingo, Matanovic Anja, Rodríguez Elke, Esparza-Gordillo Jorge, Baurecht Hansjörg, Werfel Thomas, Meyer-Hoffert Ulf, Tsoi Lam C, Nakamura Yusuke, Takahashi Atsushi, Kubo Michiaki, Tamari Mayumi, Hirota Tomomitsu, Herder Christian, Heim Katharina, Prokisch Holger, Hotze Melanie, Ellinghaus David
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies
Franke A, Büning C, Duerr R, Nöthen M, Wang J, Vatn M, Mathew C, Sanderson J, Rutgeerts P, Vermeire S, McArdle W, Strachan D, Wijmenga C, Sans M, Brand S, Glas J, Parkes M, Schreiber S, Rosenstiel P, Subramani S, Karlsen T, Nothnagel M, Daly M, D'Amato M, Halfvarson J, Annese V, Latiano A, Illig T, Winkelmann J, Ponsioen C, Weersma R, Nikolaus S, Liu X, Doncheva N, Skieceviciene J, Rivas M, Keller A, Ellinghaus E, Bromberg Y, Stade B, Jiang T, Till A, Lipinski S, Zeissig S, Zhang H, Liu Q, Jiang F, Krawczak M, Kayser M, Kupcinskas L, Vogel U, Andersen V, Lee J, Berzuini C, Goodall J, Boehm B, Häsler R, Albrecht M, Mayr G, Forster M, Ellinghaus D. Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology 2013; 145:339-47.
25.04.2013Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies
25.04.2013Gastroenterology 2013; 145:339-47
Franke Andre, Büning Carsten, Duerr Richard H, Nöthen Markus M, Wang Jun, Vatn Morten H, Mathew Christopher G, Sanderson Jeremy D, Rutgeerts Paul, Vermeire Severine, McArdle Wendy L, Strachan David P, Wijmenga Cisca, Sans Miquel, Brand Stephan, Glas Jürgen, Parkes Miles, Schreiber Stefan, Rosenstiel Philip, Subramani Suresh, Karlsen Tom H, Nothnagel Michael, Daly Mark J, D'Amato Mauro, Halfvarson Jonas, Annese Vito, Latiano Anna, Illig Thomas, Winkelmann Juliane, Ponsioen Cyriel Y, Weersma Rinse K, Nikolaus Susanna, Liu Xiao, Doncheva Nadezhda T, Skieceviciene Jurgita, Rivas Manuel A, Keller Andreas, Ellinghaus Eva, Bromberg Yana, Stade Björn, Jiang Tao, Till Andreas, Lipinski Simone, Zeissig Sebastian, Zhang Hu, Liu Qing, Jiang Fuman, Krawczak Michael, Kayser Manfred, Kupcinskas Limas, Vogel Ulla, Andersen Vibeke, Lee James, Berzuini Carlo R, Goodall Jane, Boehm Bernhard O, Häsler Robert, Albrecht Mario, Mayr Gabriele, Forster Michael, Ellinghaus David
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
Thomsen I, Vatn M, Silverberg M, Duerr R, Padyukov L, Brand S, Sans M, Annese V, Achkar J, Melum E, Durie P, Sandford R, Mayr G, König I, Hveem K, Cleynen I, Gutierrez-Achury J, Ricaño-Ponce I, van Heel D, Björnsson E, Boberg K, Marschall H, Schreiber S, Manns M, Färkkilä M, Dale A, Chapman R, Lazaridis K, Franke A, Anderson C, Cho J, Bergquist A, Alexander G, Chazouillères O, Bowlus C, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M, Rioux J, Karlsen T, Næss S, Liu J, Gotthardt D, Pares A, Ellinghaus D, Shah T, Juran B, Milkiewicz P, Rust C, Schramm C, Hirschfield G, Invernizzi P, Eksteen B, Hov J, Folseraas T, Ellinghaus E, Rushbrook S, Doncheva N, Andreassen O, Weersma R, Weismüller T, Müller T, Srivastava B, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich S, Thompson W, Mason A, Teufel A, Sterneck M, Dalekos G, Nöthen M, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen C, Croucher P, Schork A. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 2013; 45:670-5.
21.04.2013Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
21.04.2013Nat Genet 2013; 45:670-5
Thomsen Ingo, Vatn Morten H, Silverberg Mark S, Duerr Richard H, Padyukov Leonid, Brand Stephan, Sans Miquel, Annese Vito, Achkar Jean-Paul, Melum Espen, Durie Peter R, Sandford Richard N, Mayr Gabriele, König Inke R, Hveem Kristian, Cleynen Isabelle, Gutierrez-Achury Javier, Ricaño-Ponce Isis, van Heel David, Björnsson Einar, Boberg Kirsten Muri, Marschall Hanns-Ulrich, Schreiber Stefan, Manns Michael P, Färkkilä Martti, Dale Anders M, Chapman Roger W, Lazaridis Konstantinos N, Franke Andre, Anderson Carl A, Cho Judy, Bergquist Annika, Alexander Graeme, Chazouillères Olivier, Bowlus Christopher L, Wijmenga Cisca, Schrumpf Erik, Vermeire Severine, Albrecht Mario, Rioux John D, Karlsen Tom H, Næss Sigrid, Liu Jimmy Z, Gotthardt Daniel Nils, Pares Albert, Ellinghaus David, Shah Tejas, Juran Brian D, Milkiewicz Piotr, Rust Christian, Schramm Christoph, Hirschfield Gideon M, Invernizzi Pietro, Eksteen Bertus, Hov Johannes Roksund, Folseraas Trine, Ellinghaus Eva, Rushbrook Simon M, Doncheva Nadezhda T, Andreassen Ole A, Weersma Rinse K, Weismüller Tobias J, Müller Tobias, Srivastava Brijesh, Saarela Janna, Leppa Virpi, Dorfman Ruslan, Alvaro Domenico, Floreani Annarosa, Onengut-Gumuscu Suna, Rich Stephen S, Thompson Wesley K, Mason Andrew L, Teufel Andreas, Sterneck Martina, Dalekos Georgios, Nöthen Markus M, Herms Stefan, Winkelmann Juliane, Mitrovic Mitja, Braun Felix, Ponsioen Cyriel Y, Croucher Peter J P, Schork Andrew J
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
Tillack C, Koburger M, Wagner J, Glas J, Diegelmann J, Koglin S, Dombrowski Y, Schauber J, Wollenberg A, Maier H, Wetzke M, Ehmann L, Friedrich M, Laubender R, Papay P, Vogelsang H, Stallhofer J, Beigel F, Bedynek A, Brand S. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment. Gut 2013; 63:567-77.
06.03.2013Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
06.03.2013Gut 2013; 63:567-77
Tillack Cornelia, Koburger Maria, Wagner Johanna, Glas Jürgen, Diegelmann Julia, Koglin Sarah, Dombrowski Yvonne, Schauber Jürgen, Wollenberg Andreas, Maier Harald, Wetzke Martin, Ehmann Laura Maximiliane, Friedrich Matthias, Laubender Rüdiger P, Papay Pavol, Vogelsang Harald, Stallhofer Johannes, Beigel Florian, Bedynek Andrea, Brand Stephan
Moving the genetics of inflammatory bowel diseases from bench to bedside: first steps towards personalised medicine
Brand S. Moving the genetics of inflammatory bowel diseases from bench to bedside: first steps towards personalised medicine. Gut 2013; 62:1531-3.
30.01.2013Moving the genetics of inflammatory bowel diseases from bench to bedside: first steps towards personalised medicine
30.01.2013Gut 2013; 62:1531-3
Brand Stephan
IRGM variants and susceptibility to inflammatory bowel disease in the German population
Glas J, Czamara D, Diegelmann J, Göke B, Friedrich M, Steib C, Beigel F, Wetzke M, Tsekeri E, Olszak T, Fries C, Stallhofer J, Bues S, Seiderer J, Brand S. IRGM variants and susceptibility to inflammatory bowel disease in the German population. PloS one 2013; 8:e54338.
24.01.2013IRGM variants and susceptibility to inflammatory bowel disease in the German population
24.01.2013PloS one 2013; 8:e54338
Glas Jürgen, Czamara Darina, Diegelmann Julia, Göke Burkhard, Friedrich Matthias, Steib Christian, Beigel Florian, Wetzke Martin, Tsekeri Eleni, Olszak Torsten, Fries Christoph, Stallhofer Johannes, Bues Stephanie, Seiderer Julia, Brand Stephan
PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sites
Glas J, Duerr R, Franke A, Kamboh M, Achkar J, Balschun T, Müller-Myhsok B, Wolf C, Olszak T, Wetzke M, Diegelmann J, Pasciuto G, Czamara D, Seiderer J, Brand S. PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sites. PloS one 2012; 7:e52873.
27.12.2012PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sites
27.12.2012PloS one 2012; 7:e52873
Glas Jürgen, Duerr Richard H, Franke Andre, Kamboh M Ilyas, Achkar Jean-Paul, Balschun Tobias, Müller-Myhsok Bertram, Wolf Christiane, Olszak Torsten, Wetzke Martin, Diegelmann Julia, Pasciuto Giulia, Czamara Darina, Seiderer Julia, Brand Stephan
Indigestion after Digestive Disease Week (DDW): be aware of the "Golden Raspberry Award" at DDW and Cyclospora cayetanensis
Brand S, Ochsenkühn T, Hogardt M. Indigestion after Digestive Disease Week (DDW): be aware of the "Golden Raspberry Award" at DDW and Cyclospora cayetanensis. Am J Gastroenterol 2012; 107:1927-9.
01.12.2012Indigestion after Digestive Disease Week (DDW): be aware of the "Golden Raspberry Award" at DDW and Cyclospora cayetanensis
01.12.2012Am J Gastroenterol 2012; 107:1927-9
Brand Stephan, Ochsenkühn Thomas, Hogardt Michael
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Kupcinskas L, Potocnik U, Prescott N, Regueiro M, Rotter J, Russell R, Sanderson J, Sans M, Satsangi J, Schreiber S, Simms L, Sventoraityte J, Ponsioen C, Palmieri O, Kugathasan S, Latiano A, Laukens D, Lawrance I, Lees C, Louis E, Mahy G, Mansfield J, Morgan A, Mowat C, Newman W, Targan S, Taylor K, Tremelling M, Hakonarson H, Brant S, Radford-Smith G, Mathew C, Rioux J, Schadt E, Daly M, Franke A, Parkes M, Vermeire S, Barrett J, Annese V, Silverberg M, Verspaget H, De Vos M, Wijmenga C, Wilson D, Winkelmann J, Xavier R, Zeissig S, Zhang B, Zhang C, Zhao H, Cho J, Karlsen T, Jostins L, Theatre E, Spain S, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar J, Ahmad T, Amininejad L, Ananthakrishnan A, Andersen V, Cleynen I, Ning K, Ripke S, Weersma R, Duerr R, McGovern D, Hui K, Lee J, Schumm L, Sharma Y, Anderson C, Essers J, Mitrovic M, Andrews J, Baidoo L, Balschun T, Ferguson L, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Ellinghaus D, Edwards C, Bampton P, Bitton A, Boucher G, Brand S, Büning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney K, Dubinsky M, Hu X. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491:119-24.
01.11.2012Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
01.11.2012Nature 2012; 491:119-24
Kupcinskas Limas, Potocnik Uros, Prescott Natalie J, Regueiro Miguel, Rotter Jerome I, Russell Richard K, Sanderson Jeremy D, Sans Miquel, Satsangi Jack, Schreiber Stefan, Simms Lisa A, Sventoraityte Jurgita, Ponsioen Cyriel Y, Palmieri Orazio, Kugathasan Subra, Latiano Anna, Laukens Debby, Lawrance Ian C, Lees Charlie W, Louis Edouard, Mahy Gillian, Mansfield John, Morgan Angharad R, Mowat Craig, Newman William, Targan Stephan R, Taylor Kent D, Tremelling Mark, Hakonarson Hakon, Brant Steven R, Radford-Smith Graham, Mathew Christopher G, Rioux John D, Schadt Eric E, Daly Mark J, Franke Andre, Parkes Miles, Vermeire Severine, Barrett Jeffrey C, Annese Vito, Silverberg Mark S, Verspaget Hein W, De Vos Martine, Wijmenga Cisca, Wilson David C, Winkelmann Juliane, Xavier Ramnik J, Zeissig Sebastian, Zhang Bin, Zhang Clarence K, Zhao Hongyu, Cho Judy H, Karlsen Tom H, Jostins Luke, Theatre Emilie, Spain Sarah L, Raychaudhuri Soumya, Goyette Philippe, Wei Zhi, Abraham Clara, Achkar Jean-Paul, Ahmad Tariq, Amininejad Leila, Ananthakrishnan Ashwin N, Andersen Vibeke, Cleynen Isabelle, Ning Kaida, Ripke Stephan, Weersma Rinse K, Duerr Richard H, McGovern Dermot P, Hui Ken Y, Lee James C, Schumm L Philip, Sharma Yashoda, Anderson Carl A, Essers Jonah, Mitrovic Mitja, Andrews Jane M, Baidoo Leonard, Balschun Tobias, Ferguson Lynnette R, Franchimont Denis, Fransen Karin, Gearry Richard, Georges Michel, Gieger Christian, Glas Jürgen, Haritunians Talin, Hart Ailsa, Hawkey Chris, Hedl Matija, Ellinghaus David, Edwards Cathryn, Bampton Peter A, Bitton Alain, Boucher Gabrielle, Brand Stephan, Büning Carsten, Cohain Ariella, Cichon Sven, D'Amato Mauro, De Jong Dirk, Devaney Kathy L, Dubinsky Marla, Hu Xinli
Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms
Zitzmann K, Vlotides G, Brand S, Lahm H, Spöttl G, Göke B, Auernhammer C. Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms. Endocr Relat Cancer 2012; 19:423-34.
24.05.2012Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms
24.05.2012Endocr Relat Cancer 2012; 19:423-34
Zitzmann Kathrin, Vlotides George, Brand Stephan, Lahm Harald, Spöttl Gerald, Göke Burkhard, Auernhammer Christoph J
Analysis of IL12B gene variants in inflammatory bowel disease
Glas J, Czamara D, Diegelmann J, Ochsenkühn T, Göke B, Wetzke M, Steib C, Stallhofer J, Beigel F, Friedrich M, Tillack C, Fries C, Olszak T, Wagner J, Seiderer J, Brand S. Analysis of IL12B gene variants in inflammatory bowel disease. PloS one 2012; 7:e34349.
30.03.2012Analysis of IL12B gene variants in inflammatory bowel disease
30.03.2012PloS one 2012; 7:e34349
Glas Jürgen, Czamara Darina, Diegelmann Julia, Ochsenkühn Thomas, Göke Burkhard, Wetzke Martin, Steib Christian, Stallhofer Johannes, Beigel Florian, Friedrich Matthias, Tillack Cornelia, Fries Christoph, Olszak Torsten, Wagner Johanna, Seiderer Julia, Brand Stephan
PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background
Glas J, Czamara D, Diegelmann J, Karbalai N, Ochsenkühn T, Göke B, Steib C, Friedrich M, Stallhofer J, Tillack C, Beigel F, Wetzke M, Olszak T, Seiderer J, Wagner J, Brand S. PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background. PloS one 2012; 7:e33682.
21.03.2012PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background
21.03.2012PloS one 2012; 7:e33682
Glas Jürgen, Czamara Darina, Diegelmann Julia, Karbalai Nazanin, Ochsenkühn Thomas, Göke Burkhard, Steib Christian, Friedrich Matthias, Stallhofer Johannes, Tillack Cornelia, Beigel Florian, Wetzke Martin, Olszak Torsten, Seiderer Julia, Wagner Johanna, Brand Stephan
The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease
Glas J, Czamara D, Diegelmann J, Friedrich M, Steib C, Beigel F, Olszak T, Tillack C, Fries C, Wetzke M, Bayrle C, Seiderer J, Brand S. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease. PloS one 2011; 6:e29309.
29.12.2011The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease
29.12.2011PloS one 2011; 6:e29309
Glas Jürgen, Czamara Darina, Diegelmann Julia, Friedrich Matthias, Steib Christian, Beigel Florian, Olszak Torsten, Tillack Cornelia, Fries Christoph, Wetzke Martin, Bayrle Corinna, Seiderer Julia, Brand Stephan
Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease
Beigel F, Ochsenkühn T, Seiderer J, Göke B, Weidinger M, Breiteneicher S, Schnitzler F, Tillack C, Laubender R, Löhr B, Brand S. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease. Digestion 2011; 85:47-54.
14.12.2011Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease
14.12.2011Digestion 2011; 85:47-54
Beigel Florian, Ochsenkühn Thomas, Seiderer Julia, Göke Burkhard, Weidinger Maria, Breiteneicher Simone, Schnitzler Fabian, Tillack Cornelia, Laubender Rüdiger P, Löhr Beate, Brand Stephan